Higher admission serum total carbon dioxide is independently associated with early seizure recurrence in children with benign convulsions with mild gastroenteritis - Scorecard - MDSpire

Higher admission serum total carbon dioxide is independently associated with early seizure recurrence in children with benign convulsions with mild gastroenteritis

  • By

  • Ling Zou

  • Feng Li

  • Hongyu Li

  • Zhihong Su

  • June 16, 2026

  • 0 min

Share

Clinical Scorecard: Elevated serum total carbon dioxide levels at admission are linked to increased risk of early seizure recurrence in pediatric patients with benign convulsions associated with mild gastroenteritis

At a Glance

CategoryDetail
ConditionBenign convulsions associated with mild gastroenteritis (CwG)
Key MechanismsHigher admission serum total carbon dioxide (TCO2) levels are associated with increased risk of seizure recurrence.
Target PopulationChildren aged 6 months to 6 years diagnosed with CwG.
Care SettingTertiary care institution

Key Highlights

  • 26.7% of children experienced seizure recurrence within 48 hours.
  • Median TCO2 was significantly higher in the recurrence group (17.4 vs. 15.1 mmol/L).
  • Higher TCO2 levels were independently associated with recurrence (odds ratio 1.235).
  • A TCO2 cutoff of 16.25 mmol/L showed 78.3% sensitivity and 61.9% specificity.
  • Strong correlation between venous TCO2 and arterial bicarbonate (r = 0.966).

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of CwG based on clinical criteria and exclusion of other causes.

Management

  • Consider monitoring intensity based on admission TCO2 levels.

Monitoring & Follow-up

  • Observe children with higher TCO2 levels closely for seizure recurrence.

Risks

  • Younger age and higher TCO2 levels are associated with increased risk of recurrence.

Patient & Prescribing Data

Children aged 6 months to 6 years with benign convulsions and mild gastroenteritis.

Anticonvulsant use may be considered based on clinical assessment and TCO2 levels.

Clinical Best Practices

  • Utilize TCO2 as a readily accessible biomarker for risk stratification.
  • Conduct further validation in prospective cohorts.

Related Resources & Content

Original Source(s)

Related Content